Related Experiment Videos
[Stereotaxy during intravenous anesthesia with propofol]
M Fukuda1, S Kameyama, T Kawaguchi
1Department of Neurosurgery, National Nishi-Niigata Chuo Hospital, Japan.
No Shinkei Geka. Neurological Surgery
|September 23, 1998
Summary
Intravenous propofol anesthesia is effective for stereotactic surgery in movement disorders, improving patient outcomes and aiding target identification. This method offers pain relief and potential anti-parkinsonian effects, enhancing surgical precision.
Area of Science:
- Neurosurgery
- Anesthesiology
- Neurology
Context:
- Stereotactic surgery is a key treatment for movement disorders.
- Intravenous propofol anesthesia is increasingly used in neurosurgery.
- Evaluating anesthetic techniques is crucial for patient safety and surgical success.
Purpose:
- To assess the efficacy and safety of intravenous propofol anesthesia during stereotactic surgery for movement disorders.
- To evaluate the impact of propofol on patient outcomes, including motor function and activities of daily living (ADL).
- To determine the utility of propofol anesthesia in wake-up tests for neural noise recording and target identification.
Summary:
- A retrospective review of 30 patients undergoing stereotactic surgery for movement disorders under propofol anesthesia showed significant improvements in motor and ADL scores for Parkinson's disease patients.
- Propofol anesthesia facilitated wake-up tests for neural noise recording, aiding target identification, and tremor suppression in 17 patients.
- Adverse events were minimal, with one allergic reaction; however, three juvenile parkinsonian patients experienced dopa-induced dyskinesia (DID) during propofol infusion, suggesting a potential anti-parkinsonian effect.
Impact:
- Intravenous propofol anesthesia is a safe and effective anesthetic method for stereotactic surgery in movement disorders.
- Propofol facilitates intraoperative monitoring and potentially offers therapeutic benefits for Parkinson's disease symptoms.
- The findings support the continued use of propofol in stereotactic neurosurgery, optimizing patient care and surgical outcomes.